Marijuana U.S.A.

Werbung:
"The Senate Homeland Security and Governmental Affairs Committee voted 9-5 to approve legislation which will eliminate the ability of federal agencies to disqualify applicants for federal jobs and security clearances solely for prior cannabis use.

S. 4711, the Dismantling Outdated Obstacles and Barriers to Individual Employment (
DOOBIE) Act, was introduced by committee chair Sen. Gary Peters (D-MI) earlier this summer and was quickly scheduled for a vote in July before being postponed until this week. The bill will greatly diminish the discrimination that people who have used cannabis face when trying to get federal employment and security clearances, improving both the operation of federal agencies and national security by significantly expanding the talent pool that is eligible for these roles.

The legislation will now be considered by the full Senate,
though it is
unclear when it will be brought to the floor for a vote.

“At a time when
most Americans think cannabis should be legal and most states allow its use in some form, it is ridiculous for the federal government to continue these outdated, unfair, and frankly dangerous hiring and security clearance approval policies,” said NORML Political Director Morgan Fox. “We are putting ourselves at a tremendous disadvantage as a nation by barring qualified individuals who have used cannabis from civil service. NORML strongly urges congressional leadership to expedite passage of this legislation immediately.”
.
 
"Adults who regularly consume medical cannabis products do not experience any significant adverse changes in either brain morphology or cognitive performance, according to longitudinal data published in the journal JAMA (Journal of the American Medical Association) Network Open.

Researchers affiliated with Harvard Medical School and the McGovern Institute for Brain Research at the Massachusetts Institute of Technology collected
structural and functional brain imaging (fMRI) data from a cohort of newly authorized medical cannabis patients at baseline and one-year later. Similar data was also collected for healthy controls (non-cannabis consumers).

Investigators "did not observe functional differences between baseline and brain activation at one-year during working memory, reward processing, or inhibitory control tasks,” nor did they identify “an association between changes in cannabis use frequency and brain activation.”
.

The findings are consistent with numerous prior studies concluding that cannabis exposure is not negatively associated with significant changes in either brain morphology or cognitive functioning in either young people or adults. Other studies have determined that medical cannabis patients “exhibit enhanced rather than impaired executive function over time."
.
 
"After the rockiest of starts, the regulated marijuana market is finally coming to life in New York state.

Cannabis retailers reported $429.9 Million in revenue from January through the end of August, a month in which weekly sales surpassed $20 Million for the first time.

At this pace – and with an estimated 200 licensed retailers ready to open for business by the end of September – finishing 2024 with
more than $1 Billion in regulated marijuana sales is “within the realm of plausibility,” a top cannabis regulator said."
.
 
"Medical cannabis access is associated with significant decreases in employees’ healthcare premiums, according to data published in the journal Applied Health Economics and Health Policy.

Researchers affiliated with the medical cannabis technology company Leafwell assessed the relationship between medical cannabis legalization laws and employer-sponsored healthcare premiums over ten years (2003-2022)."

.
 
Werbung:
Back
Top